https://www.indianpharmapost.com/vivimed-labs-to-manufacture-market-favipiravir-tablets-85612021-05-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/crisil-assigns-positive-outlook-to-jubilant-pharmovas-long-term-rating-85622021-05-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-reports-net-profit-of-rs-7194-cr-in-q4fy21-85682021-05-11T00:00:00+05:30always0.9